Avego BioScience Capital — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Immunocoreimmunocore.com inNASDAQ: IMCRJul 2022

Immunocore is a biotechnology company developing T cell receptor (TCR) based immunomodulating therapies for patients with cancer, infectious diseases, and autoimmune diseases.

BiotechHealthtechAbingdon, Oxfordshire

Brian Di Donato(Chief Financial Officer)David Berman(Head of Research and Development)inTina St. Leger(Chief Human Resources Officer)inBahija Jallal(Chief Executive Officer)inRobert Perez(Director)Peter Ratcliffe(Director)

Co-investorsGeneral Atlantic JDRF T1D Fund Rosetta Capital Ltd.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.